Cognetivity Neurosciences Announces Commercial Agreement With Mediclinic to Provide Cognitive Assessment to Over 50s
Cognetivity Neurosciences Announces Commercial Agreement With Mediclinic to Provide Cognitive Assessment to Over 50s
Program Designed to Identify Age-Related Brain Health Issues at an Early Stage, Allowing Effective Provision of Coordinated Care
旨在早期識別與年齡相關的腦健康問題的計劃,允許提供有效的協調護理
Vancouver, British Columbia--(Newsfile Corp. - October 3, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTC Pink: CGNSF) (FSE: 1UB) ("the Company" or "Cognetivity"), a leading AI healthcare technology company, is delighted to announce a collaboration with the Mediclinic Group ("Mediclinic"), a prominent international private hospital group operating across Europe, the Middle East and Southern Africa. This pivotal partnership will start in the United Arab Emirates and is set to revolutionize brain health diagnosis and care in the region, effectively addressing the escalating concern around Alzheimer's disease and other cognitive health issues. Under this commercial engagement, Cognetivity's state-of-the-art cognitive assessment platform, CognICA, will be seamlessly integrated into Mediclinic's healthcare services. CognICA harnesses the power of artificial intelligence (AI) and machine learning to deliver rapid, accurate, and non-invasive cognitive assessments, allowing accurate, early detection of brain health issues. This strategic partnership underscores the commitment of both Cognetivity and Mediclinic to take a proactive stance against the rising challenges around brain health.
溫哥華,不列顛哥倫比亞省-(Newsfile Corp.-2023年10月3日)-認知神經科學有限公司(CSE:CGN)(場外交易代碼:CGNSF)(FSE:1UB)(“公司”或“認知”)領先的人工智慧醫療保健技術公司,很高興地宣佈與Mediclinic Group(“Mediclinic”)達成合作,Mediclinic Group是一家著名的國際私立醫院集團,業務遍及歐洲、中東和南部非洲。這一關鍵的夥伴關係將從阿拉伯聯合酋長國開始,並將徹底改變該地區的大腦健康診斷和護理,有效地解決圍繞阿爾茨海默氏症和其他認知健康問題的不斷升級的擔憂。根據這一商業合作,Cognetivity最先進的認知評估平臺CognICA將無縫集成到Mediclinic的醫療保健服務中。CognICA利用人工智慧(AI)和機器學習的力量來提供快速、準確和非侵入性的認知評估,從而能夠準確、早期地檢測大腦健康問題。這一戰略合作夥伴關係強調了Cognetivity和Mediclinic對大腦健康方面日益嚴峻的挑戰採取積極主動的立場的承諾。
The collaboration will roll out in a phased approach, commencing with the inclusion of CognICA into Mediclinic's Healthy Aging Program. This initial phase empowers family medicine doctors, geriatricians, and neurologists across select clinics and hospitals to conduct cognitive screenings on individuals aged 50 and above. By identifying cognitive impairments early on, interventions are much more effective, and this initiative aligns with Mediclinic's dedication to preventative care, promoting optimal patient well-being and quality of life.
合作將分階段展開,首先將CognICA納入Mediclinic的健康老齡化計劃。這一初始階段使家庭醫學醫生、老年病醫生和神經科醫生能夠在選定的診所和醫院對50歲及以上的個人進行認知篩查。通過及早識別認知障礙,幹預措施更加有效,這一舉措與Mediclinic致力於預防性護理,促進最佳患者福祉和生活品質相一致。
As the engagement progresses, CognICA will further enhance Mediclinic's Cognitive Diagnostic Pathway, facilitating precise evaluations and tailored recommendations by neurologists. Additionally, the partnership will extend to the clinical services of Park View Hospital, expanding the reach of cognitive screening and monitoring to a diverse patient population and improving patient outcomes in this rapidly growing at-risk group.
隨著合作的進展,CognICA將進一步加強Mediclinic的認知診斷途徑,促進神經學家的準確評估和量身定製的建議。此外,合作夥伴關係還將擴展到Park View醫院的臨床服務,將認知篩查和監測的範圍擴大到不同的患者群體,並改善這一快速增長的高危群體的患者結局。
"Through this strategic partnership, Cognetivity and Mediclinic are reshaping the landscape of brain health care in the UAE," commented Mazen Sobh, Vice President of Commercial Development at Cognetivity. "Our joint effort leverages technological innovation and medical expertise to drive impactful change in how cognitive health is diagnosed and managed. CognICA's unique attributes are ideal for the delivery of effective, early detection of brain health issues and we look forward to expanding our work with Mediclinic as we move forwards."
“通過這一戰略合作夥伴關係,Cognetivity和Mediclinic正在重塑阿聯酋腦保健領域的格局,”Cognetivity負責商業發展的副總裁Mazen Sobh評論道。我們的共同努力利用技術創新和醫療專業知識,推動認知健康診斷和管理方式的有效變化。CognICA的獨特屬性是提供有效、早期發現大腦健康問題的理想選擇,我們期待著在向前發展的過程中擴大我們與Mediclinic的合作。“
Willie Willemse, Chief Strategy Officer at Mediclinic Middle East, echoed the sentiment, saying, "This collaboration signifies Mediclinic's commitment to advancing patient care in the UAE. By integrating CognICA, we are embracing a proactive approach to cognitive health, ensuring that our patients receive the highest standard of care and support."
Mediclinic中東公司首席戰略官Willie Willemse呼應了這一觀點,他說:“這一合作標誌著Mediclinic致力於推進阿聯酋的患者護理。通過整合CognICA,我們正在接受一種積極主動的認知健康方法,確保我們的患者得到最高標準的護理和支持。”
This strategic partnership represents a significant step toward addressing the growing challenge of cognitive health disorders in the UAE, emphasizing the commitment of both organizations to improving patient outcomes and overall quality of life.
這一戰略合作夥伴關係代表著朝著解決阿聯酋認知健康障礙日益嚴峻的挑戰邁出的重要一步,強調了兩家組織對改善患者結局和整體生活品質的承諾。
Cognetivity Neurosciences' mission is to utilize its AI platform technology to transform the landscape of brain health globally, enhance the quality of care provided to patients and to reduce the burden and cost to providers and payers, delivering the company's vision of A Brighter Mind for a Fuller Life.
認知神經科學的使命是利用其人工智慧平臺技術來改變全球大腦健康的格局,提高向患者提供的護理質量,並減少提供者和付款人的負擔和成本,實現公司為富勒生活提供更光明心靈的願景。
About Cognetivity Neurosciences
關於認知神經科學
Cognetivity is a technology company that has developed a cognitive testing platform for use in medical, commercial, and consumer environments. Cognetivity's CognICATM uses artificial intelligence and machine learning technology to test the performance of large areas of the brain to help detect early signs of cognitive dysfunction. CognICA is currently available for clinical use in the United States, United Kingdom, Europe, Canada and the Middle East, with regulatory approval in other regions expected later in 2023.
Cognetivity是一家技術公司,它開發了一種認知測試平臺,用於醫療、商業和消費環境。認知性的認知ICATM使用人工智慧和機器學習技術來測試大腦大片區域的表現,以幫助檢測認知功能障礙的早期跡象。CognICA目前在美國、英國、歐洲、加拿大和中東可用於臨床,其他地區的監管部門預計將於2023年晚些時候批准。
About Mediclinic Group
Mediclinic is a diversified international private healthcare services group, established in South Africa in 1983, with divisions in Switzerland, Southern Africa (South Africa and Namibia) and the Middle East. Mediclinic is focused on providing specialist-orientated, multi-disciplinary services across the continuum of care in such a way that the Group will be regarded as the most respected and trusted provider of healthcare services by patients, medical practitioners, funders and regulators of healthcare in each of its markets.
關於Mediclinic Group
Mediclinic是一家多元化的國際私營醫療服務集團,於1983年在南非成立,在瑞士、南部非洲(南非和納米比亞)和中東設有分支機構。Mediclinic專注於在整個護理過程中提供以專家為導向的多學科服務,以使該集團被其每個市場的患者、醫生、資助者和監管機構視為最受尊重和信任的醫療服務提供商。
On behalf of the Board of Directors
我謹代表董事會
"Sina Habibi"
Sina Habibi
《新浪哈比比》
新浪哈比比
Chief Executive Officer and Director
董事首席執行官兼首席執行官
Forward-Looking Statements:
前瞻性陳述:
Certain statements contained in this news release, including those identified by the words "anticipate," "assume," "believe," "plan," "estimate," "expect," "intend," "may," "should" and similar expressions, to the extent they relate to the Company or its management, constitute forward-looking information or statements (collectively, the "Forward-Looking Statements"). These forward-looking statements are not historical facts and reflect current expectations regarding future results or events. This news release contains forward-looking statements. These forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Such statements are based on current expectations and various estimates, factors and assumptions, and involve known and unknown risks, uncertainties and other factors. Such statements and information are based on a number of assumptions regarding our current and future business strategies and the environment in which we operate. We assume no responsibility to update or revise forward-looking information to reflect new events or circumstances, except as required by law. Readers are cautioned not to place undue reliance on our forward-looking statements.
本新聞稿中包含的某些陳述,包括“預期”、“假設”、“相信”、“計劃”、“估計”、“預期”、“打算”、“可能”、“應該”以及類似的表述,在與公司或其管理層有關的範圍內,構成前瞻性資訊或陳述(統稱為“前瞻性陳述”)。這些前瞻性陳述不是歷史事實,反映了對未來結果或事件的當前預期。本新聞稿包含前瞻性陳述。這些前瞻性陳述不是對未來業績的保證,涉及難以預測的風險、不確定性和假設。此類陳述基於當前預期和各種估計、因素和假設,涉及已知和未知的風險、不確定性和其他因素。這些陳述和資訊是基於對我們當前和未來的業務戰略以及我們所處的經營環境的一些假設。除法律要求外,我們不承擔更新或修改前瞻性資訊以反映新事件或新情況的責任。告誡讀者不要過度依賴我們的前瞻性陳述。
The Canadian Securities Exchange is not responsible for the adequacy or accuracy of this release.
加拿大證券交易所不對本新聞稿的充分性或準確性負責。
For more information, please visit: website: or contact: info@cognetivity.com; media inquiries can be sent to pr@cognetivity.com.
如需更多資訊,請訪問:網站:或聯繫方式:info@cognetivity.com;媒體查詢可發送至pr@cognetivity.com。
To view the source version of this press release, please visit
要查看本新聞稿的源版本,請訪問